VaxGen, Chemo-Sero-Therapeutic Research Institute deal

VXGN will develop in the U.S. the LC16-Kaketsuken smallpox vaccine from the institute. The vaccine is based on the LC16m8 clone of the internationally accepted Lister strain of vaccinia virus. VXGN pl...